PET technologists are exposed to radiation during the manual preparation and handling of FDG for PET imaging. The amount of radiation dose absorbed varies based on the time and frequency of exposure, and the amount of shielding used. Validation tests confirm that MEDRAD's Intego™ PET Infusion System reduces the radiation dose from preparation and handling by more than 20%.
At the University of Michigan, Intego helped reduce the time and radiation dose required for dose preparation.
According to Geralyn Will, Clinical Director of Operation at the University of Michigan, "Moving to the Intego PET Infusion System has allowed us to improve our workflow in our hot lab. We no longer have the technologists going in and out of the hot lab for FDG all day. The FDG is loaded into the infusion system once in the morning and once in the afternoon. This has also contributed to our being able to reduce the radiation hand dosages that our technologists are receiving as they no longer have to handle the dose for every patient."
Intego automatically measures and delivers patient-specific Fluorodeoxyglucose (FDG) doses on demand. With on-board dosimetry, the system can deliver precise, repeatable FDG doses within +/- 2% of the measured dose. The Intego also minimizes FDG handling and is fully shielded, reducing radiation exposure by more than 20% compared to conventional (syringe-based) FDG delivery methods.
”Intego technology is raising the standard of care in FDG delivery,” says Doug Descalzi, Executive Director of MEDRAD’s Molecular Imaging business. “Healthcare professionals gain precision, flexibility and control over workflow, which can help any PET practice grow clinically and safely.”